Hormone declines during menopause can cause genitourinary syndrome of menopause (GSM), a cluster of vulvovaginal and urinary symptoms that can significantly impair a woman’s quality of life. Local estrogen therapy is effective in relieving genitourinary symptoms, but a new study, published in Menopause, suggests nonablative capacitive-resistive monopolar radiofrequency (CRMRF) may also be effective in restoring vaginal and sexual health.
This article was originally published on MedicalXpress.com
